This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LTC Edward R. Carter, MC, USA
Division of Pediatric Pulmonology Madigan Army Medical Center Tacoma, WA 98431-5000

Arch Pediatr Adolesc Med. 1994;148(12):1352-1353.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The use of a spacer with face mask to administer aerosolized medication to infants and toddlers is controversial. Hickey et al¹ evaluated the use of a "homemade" spacer to administer low-dose albuterol (two puffs, or 180 µg given twice, 20 minutes apart) to infants and toddlers presenting to the emergency department with wheezing. The study has problems that make it difficult for me to accept the authors' conclusions that the low dose of albuterol they administered via spacer with face mask to young children presenting to the emergency department with wheezing resuited in significant clinical improvement. I also believe that this study and its conclusions send a wrong message: low-dose albuterol administered via metered-dose inhaler with a spacer (MDI-S) and face mask is an acceptable alternative to standard nebulizer therapy in infants and toddlers. I note the following three major problems with the study: (1) the spacer device employed; . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?